Cefepime dihydrochloride monohydrate is a fourth-generation cephalosporin antibiotic widely utilized in clinical settings to treat moderate to severe infections, including pneumonia and complicated urinary… Read more










Cefepime dihydrochloride monohydrate is a fourth-generation cephalosporin antibiotic widely utilized in clinical settings to treat moderate to severe infections, including pneumonia and complicated urinary tract or skin structure infections caused by multidrug-resistant Gram-negative bacteria. Its bactericidal action results from the inhibition of bacterial cell wall synthesis. This category contains essential reference standards for the active pharmaceutical ingredient, alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities, chiral impurities such as anti-cefepime, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these high-quality standards for rigorous impurity profiling, analytical testing, and method validation to ensure the quality and consistency of drug batches. By providing precise chemical references, these materials support the development and regulatory compliance of pharmaceutical products throughout the manufacturing lifecycle and quality control process.